CRBN Structural Biology Services
Targeted protein degradation of disease-causing proteins by the E3 ligase cereblon (CRBN) represents a new therapeutic strategy for addressing challenging-to-treat diseases.
To support drug discovery programs, we have established off-the-shelf crystallization and cryo-EM systems to enable the determination of high-resolution X-ray crystal structures with a short turnaround time. Together with our protein production service and off-the-shelf biochemical and biophysical assays, we can provide a broad range of data to accelerate and support your drug development programs.
Structural Biology_CRBN Service Platform
Related Content
The ErbB family of receptor tyrosine kinases are involved in key cellular functions, including cell growth and survival. ErbB family...
VIEW RESOURCEWithin the phosphatidylinositol 3-kinase (PI3K) family, the heterodimer comprising the p110-α catalytic and p85-α regulatory subunits (encoded by PIK3CA and...
VIEW RESOURCE